Viewing StudyNCT00348140



Ignite Creation Date: 2024-05-05 @ 4:55 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00348140
Status: COMPLETED
Last Update Posted: 2017-09-05
First Post: 2006-06-30

Brief Title: Rosiglitazone Extended Release Tablets As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimers Disease
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Alzheimers Disease
Keywords:
Name View
cognition View
adjunctive therapy View
moderate View
Alzheimers disease View
apolipoprotein E View
mild View
rosiglitazone View